The landscape of cancer treatment is constantly evolving, with a growing spotlight on identifying novel therapeutic targets for drug creation. Traditional therapies often target rapidly dividing cells, leading to significant side effects. However, the emergence of sophisticated genomic profiling techniques has transformed our knowledge of cancer bi